Afya (NASDAQ:AFYA) Upgraded to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Afya (NASDAQ:AFYAGet Rating) from a hold rating to a buy rating in a report released on Wednesday, Zacks.com reports. Zacks Investment Research currently has $12.00 price target on the stock.

According to Zacks, “Afya Limited is a medical education group primarily in Brazil. Afya Limited is based in NEW YORK. “

Several other equities research analysts have also commented on AFYA. Credit Suisse Group upgraded shares of Afya from a neutral rating to an outperform rating and boosted their price target for the company from $18.00 to $19.00 in a report on Friday, April 8th. UBS Group reduced their price target on shares of Afya from $27.00 to $21.00 and set a buy rating for the company in a report on Monday, March 7th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Afya has an average rating of Buy and a consensus price target of $20.13.

Shares of AFYA opened at $11.73 on Wednesday. Afya has a 1-year low of $9.53 and a 1-year high of $28.23. The company has a 50-day moving average of $13.53 and a 200 day moving average of $13.74. The firm has a market capitalization of $1.08 billion, a price-to-earnings ratio of 23.46, a PEG ratio of 0.62 and a beta of 1.08. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.49 and a quick ratio of 1.56.

Afya (NASDAQ:AFYAGet Rating) last announced its quarterly earnings data on Monday, May 23rd. The company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.32. Afya had a net margin of 13.03% and a return on equity of 8.07%. During the same quarter last year, the business posted $0.21 earnings per share. On average, equities analysts anticipate that Afya will post 0.77 earnings per share for the current fiscal year.

Institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. grew its position in shares of Afya by 4.5% in the 4th quarter. Russell Investments Group Ltd. now owns 1,466,305 shares of the company’s stock worth $23,034,000 after buying an additional 63,230 shares during the last quarter. Trexquant Investment LP purchased a new position in shares of Afya in the 3rd quarter worth approximately $213,000. TimesSquare Capital Management LLC grew its position in shares of Afya by 3.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 900,400 shares of the company’s stock worth $14,145,000 after buying an additional 30,200 shares during the last quarter. Brookfield Asset Management Inc. purchased a new position in shares of Afya in the 3rd quarter worth approximately $1,753,000. Finally, Pendal Group Ltd purchased a new position in shares of Afya in the 1st quarter worth approximately $13,120,000. 57.03% of the stock is currently owned by hedge funds and other institutional investors.

Afya Company Profile (Get Rating)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Further Reading

Get a free copy of the Zacks research report on Afya (AFYA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.